Literature DB >> 36271436

Susceptibility of primary, secondary and suspected vectors to Plasmodium vivax and Plasmodium falciparum infection in Ethiopia.

Arega Tsegaye1,2,3, Assalif Demissew4,5,6, Dawit Hawaria5,7,6, Hallelujah Getachew5,8,6, Kassahun Habtamu9,6,10, Abebe Asale11, Guiyun Yan12, Delenasaw Yewhalaw5,6.   

Abstract

BACKGROUND: Insecticide-based vector control interventions in combination with case management with artemisinin-based combination therapy has reduced malaria incidence and prevalence worldwide. Current control methods focus on the primary malaria vectors, Anopheles gambiae sensu lato (s.l.) and the An. funestus group; however, the impact of secondary and suspected vectors has been either sidelined or received limited attention. Defining the susceptibility of secondary, suspected vector species to different parasites in time and space is essential for efficient malaria control and elimination programs. The aim of this study was to assess the susceptibility of An. gambiae s.l., An. coustani complex and An. pharoensis to Plasmodium vivax and P. falciparum infection in Ethiopia.
METHODS: Larvae of Anopheles spp. were collected from different aquatic habitats and reared to adults under laboratory conditions, with the temperature and humidity maintained at 27 ± 1 °C and 75 ± 5%, respectively. Adult female mosquitoes were identified to species as An. gambiae s.l., An. coustani complex and An. pharoensis. Females of these three Anopheles spp. were allowed to feed in parallel feeding assays on infected blood containing the same gametocytes isolated from P. falciparum and P. vivax gametocyte-positive patients by indirect membrane feeding assays. All blood-fed mosquitoes were held under laboratory conditions. After 7 days, all surviving mosquitoes were dissected to detect mid-gut oocyst and enumerated under a microscope.
RESULTS: Of 5915 female Anopheles mosquitoes exposed to gametocyte-infected blood, 2106 (35.6%)s fed successfully in the 32 independent infection experiments. There was a significant variation in feeding rates among An. gambiae s.l., An. pharoensis and An. coustani complex (G-test = 48.43, P = 3.049e-11). All three exposed mosquito species were receptive to P. vivax and P. falciparum infection development. The percentage of infected mosquitoes following feeding on an infected blood meal was significantly different among species (G-test = 6.49, P = 0.03886). The median infection intensity (II) for An. coustani complex, An. gambiae s.l. and An. pharoensis was 1.16, 2.00 and 1.25, respectively. Although the proportion of infected mosquitoes significantly differed in terms of II, infection rate (IR) and mean oocyst density among the species, mean oocyst density and IR were highly correlated with gametocyte density in all tests (P < 0.001).
CONCLUSION: Primary, secondary and suspected vectors were experimentally susceptible to both P. vivax and P. falciparum infection. An effective malaria elimination program might include surveillance and control tools which target secondary and suspected vectors that might play an outdoor transmission role, possibly resulting in reduced focal malaria transmission. Comparison of the three species' mean infection rates with standard deviation.
© 2022. The Author(s).

Entities:  

Keywords:  Anopheles; Ethiopia; Infection rate; Malaria; Membrane feeding assay; Oocysts; Plasmodium species

Year:  2022        PMID: 36271436     DOI: 10.1186/s13071-022-05467-5

Source DB:  PubMed          Journal:  Parasit Vectors        ISSN: 1756-3305            Impact factor:   4.047


  18 in total

1.  OBSERVATIONS ON NULLIPAROUS AND PAROUS RATES IN A POPULATION OF ANOPHELES FUNESTUS IN EAST AFRICA.

Authors:  M T GILLIES; T J WILKES
Journal:  Ann Trop Med Parasitol       Date:  1963-06

2.  THE ROLE OF SECONDARY VECTORS OF MALARIA IN NORTH-EAST TANGANYIKA.

Authors:  M T GILLIES
Journal:  Trans R Soc Trop Med Hyg       Date:  1964-03       Impact factor: 2.184

3.  OBSERVATIONS ON NULLIPAROUS AND PAROUS RATES IN SOME COMMON EAST AFRICAN MOSQUITOES.

Authors:  M T GILLIES
Journal:  Ann Trop Med Parasitol       Date:  1963-12

Review 4.  Malaria vector ecology and genetics.

Authors:  G B White
Journal:  Br Med Bull       Date:  1982-05       Impact factor: 4.291

Review 5.  Effect of irrigation and large dams on the burden of malaria on a global and regional scale.

Authors:  Jennifer Keiser; Marcia Caldas De Castro; Michael F Maltese; Robert Bos; Marcel Tanner; Burton H Singer; Jürg Utzinger
Journal:  Am J Trop Med Hyg       Date:  2005-04       Impact factor: 2.345

6.  Analysis of Anopheles arabiensis blood feeding behavior in southern Zambia during the two years after introduction of insecticide-treated bed nets.

Authors:  Christen M Fornadel; Laura C Norris; Gregory E Glass; Douglas E Norris
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

7.  Unexpected anthropophily in the potential secondary malaria vectors Anopheles coustani s.l. and Anopheles squamosus in Macha, Zambia.

Authors:  Christen M Fornadel; Laura C Norris; Veronica Franco; Douglas E Norris
Journal:  Vector Borne Zoonotic Dis       Date:  2010-12-13       Impact factor: 2.133

8.  Spatial and temporal variations of malaria epidemic risk in Ethiopia: factors involved and implications.

Authors:  Tarekegn Abose Abeku; Gerrit J van Oortmarssen; Gerard Borsboom; Sake J de Vlas; J D F Habbema
Journal:  Acta Trop       Date:  2003-08       Impact factor: 3.112

9.  First detection of Anopheles stephensi Liston, 1901 (Diptera: culicidae) in Ethiopia using molecular and morphological approaches.

Authors:  Tamar E Carter; Solomon Yared; Araya Gebresilassie; Victoria Bonnell; Lambodhar Damodaran; Karen Lopez; Mohammed Ibrahim; Seid Mohammed; Daniel Janies
Journal:  Acta Trop       Date:  2018-09-03       Impact factor: 3.112

10.  Severe Plasmodium vivax malaria, Brazilian Amazon.

Authors:  Márcia A Alexandre; Cynthia O Ferreira; André M Siqueira; Belisa L Magalhães; Maria Paula G Mourão; Marcus V Lacerda; Maria das Gracas C Alecrim
Journal:  Emerg Infect Dis       Date:  2010-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.